Humanized antibodies that recognize beta amyloid peptide

Humanized antibodies that recognize beta amyloid peptide

G Basi, JW Saldanha, DB Schenk - US Patent 9,051,363, 2015 - Google Patents
The invention provides improved agents and methods for treatment of diseases associated
with amyloid deposits of Aβ in the brain of a patient. Preferred agents include humanized
antibodies.


For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Jason Lee
jason@pepmic.com
Pepmic Co., Ltd
www.pepmic.com

评论

此博客中的热门博文

AGTR1 Antibody

Contact Information - Jason Lee

적당한운동이노화에의한포유동물면역기능의변화에미치는영향